Takashi Seto
Impact in
- Oncology top 0.2%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 280
- Lung Cancer Diagnosis and Treatment 107
- Gastric Cancer Management and Outcomes 22
- Oncology 263
- Lung Cancer Research Studies 142
- Colorectal Cancer Treatments and Studies 75
- Cancer Immunotherapy and Biomarkers 27
- Co-authors
- Nobuyuki Yamamoto (80 shared papers)Kazuhiko Nakagawa (100 shared papers)Makoto Nishio (79 shared papers)Isamu Okamoto (40 shared papers)Toyoaki Hida (48 shared papers)Masahiro Fukuoka (19 shared papers)Kōichi Goto (64 shared papers)Gouji Toyokawa (49 shared papers)
- Journals
- Journal of Clinical Oncology (66 papers)Annals of Oncology (47 papers)Journal of Thoracic Oncology (32 papers)Lung Cancer (24 papers)Clinical Lung Cancer (12 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Takashi Seto
342 papers receiving 8.6k citations
Takashi Seto's Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 6.1k
- Pulmonary and Respiratory Medicine 6.6k
- Cancer Research 1.2k
- Molecular Biology 2.2k
- Pathology and Forensic Medicine 498
Countries citing papers authored by Takashi Seto
This map shows the geographic impact of Takashi Seto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Seto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Seto more than expected).
Fields of papers citing papers by Takashi Seto
This network shows the impact of papers produced by Takashi Seto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Seto. The network helps show where Takashi Seto may publish in the future.
Co-authors
The 25 scholars most cited alongside Takashi Seto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 365 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study Hit paper breakdown → | 2014 | 561 |
| 2 | CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study Hit paper breakdown → | 2013 | 449 |
| 3 | Prophylactic cranial irradiation versus observation in patients with extensive-disease small-cell lung cancer: a multicentre, randomised, open-label, phase 3 trial Hit paper breakdown → | 2017 | 308 |
| 4 | 2006 | 282 | |
| 5 | 2006 | 270 | |
| 6 | Phase II Study of Crizotinib in East Asian Patients With ROS1-Positive Advanced Non–Small-Cell Lung Cancer Hit paper breakdown → | 2018 | 225 |
| 7 | 2016 | 222 | |
| 8 | 2010 | 220 | |
| 9 | 2006 | 181 | |
| 10 | 2010 | 140 | |
| 11 | 2006 | 139 | |
| 12 | 2009 | 131 | |
| 13 | 2012 | 118 | |
| 14 | 2016 | 106 | |
| 15 | 2019 | 104 | |
| 16 | 2016 | 95 | |
| 17 | 2015 | 93 | |
| 18 | 2014 | 86 | |
| 19 | 2015 | 84 | |
| 20 | 2019 | 84 |
About Takashi Seto
Takashi Seto is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 365 papers that have together received 8.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (280 papers), Lung Cancer Research Studies (142 papers), Lung Cancer Diagnosis and Treatment (107 papers), Colorectal Cancer Treatments and Studies (75 papers), Cancer Genomics and Diagnostics (38 papers), Cancer therapeutics and mechanisms (37 papers), Cancer Immunotherapy and Biomarkers (27 papers) and Gastric Cancer Management and Outcomes (22 papers). The work is most often cited by research in Oncology (6.1k citations), Pulmonary and Respiratory Medicine (6.6k citations), Cancer Research (1.2k citations), Molecular Biology (2.2k citations) and Pathology and Forensic Medicine (498 citations). Takashi Seto has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Nobuyuki Yamamoto, Kazuhiko Nakagawa, Makoto Nishio, Isamu Okamoto, Toyoaki Hida, Masahiro Fukuoka, Kōichi Goto, Gouji Toyokawa, Takeharu Yamanaka and Yukito Ichinose. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.